Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option

被引:12
|
作者
Flitcroft, Kathy L. [1 ]
Irwig, Les M. [1 ]
Carter, Stacy M. [1 ]
Salkeld, Glenn P. [1 ]
Gillespie, James A. [1 ]
机构
[1] A28 Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia
来源
BMC GASTROENTEROLOGY | 2012年 / 12卷
基金
英国医学研究理事会;
关键词
Screening objectives; Colorectal cancer; Fecal occult blood testing; Harm minimization; Equity; Economic efficiency; Prevention; Participation; BOWEL-CANCER; AMERICAN-COLLEGE; PROGRAM; PARTICIPATION; COLONOSCOPY;
D O I
10.1186/1471-230X-12-183
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: There are many test options available for colorectal cancer screening. The choice of test relates to the objectives of those offering or considering screening. Discussion: While all screening programs aim to detect disease early in order to improve the length and/or quality of life for the individual, some organizations and individuals prefer screening tests that offer the opportunity for cancer prevention. Others favor maximizing participation or the opportunity for shared decision-making, including discussion of information on test quality and availability. We propose three additional objectives for screening: minimizing harms, optimizing economic efficiency and maximizing equity of access to screening. Summary: Applying these objectives to colorectal cancer screening, we advocate the use of immunochemical FOBTs as the preferred screening strategy, as it satisfies all three of these important objectives.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Immunochemical Fecal Occult Blood Tests Detect Earlier Stage Colorectal
    Cole, Stephen R.
    Lane, Joanne M.
    Smith, Alicia
    Morcom, Joylene M.
    Young, Graeme P.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S190 - S191
  • [22] Evaluation of Fecal Immunochemical Tests for Colorectal Cancer Screening
    Daly, Jeanette M.
    Bay, Camden P.
    Levy, Barcey T.
    [J]. JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2013, 4 (04): : 245 - 250
  • [23] Quantitative fecal immunochemical tests for colorectal cancer screening
    Gies, Anton
    Bhardwaj, Megha
    Stock, Christian
    Schrotz-King, Petra
    Brenner, Hermann
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (02) : 234 - 244
  • [24] Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests
    Meklin, Jannica
    Syrjanen, Kari
    Eskelinen, Matti
    [J]. ANTICANCER RESEARCH, 2020, 40 (07) : 3591 - 3604
  • [25] Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: A randomized, controlled trial
    Hoffman, Richard M.
    Steel, Susan
    Yee, Ellen F. T.
    Massie, Larry
    Schrader, Ronald M.
    Murata, Glen H.
    [J]. PREVENTIVE MEDICINE, 2010, 50 (5-6) : 297 - 299
  • [26] Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?
    Quintero, Enrique
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2009, 32 (08): : 565 - 576
  • [27] A comparison of fecal occult-blood tests for colorectal-cancer screening
    Allison, JE
    Tekawa, IS
    Ransom, LJ
    Adrain, AL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03): : 155 - 159
  • [28] Three consecutive fecal occult blood tests in screening for colorectal polyps and cancer
    Luo, Hanqing
    Wu, Dong
    Fei, Guijun
    Shu, Huijun
    Li, Jingnan
    Qian, Jiaming
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 341 - 341
  • [29] A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening
    Murphy, Caitlin C.
    Sen, Ahana
    Watson, Bianca
    Gupta, Samir
    Mayo, Helen
    Singal, Amit G.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (02) : 278 - 287
  • [30] Immunochemical Fecal Occult Blood Tests for Colorectal Cancer Screening: Point-of-care tests are not tenable for a quality-assured Program
    Haug, Ulrike
    Becker, Nikolaus
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (10) : 729 - U191